Endothelin B.sub.1, (ETB.sub.1) receptor polypeptide and its encoding nucleic acid methods, and uses thereof
AssigneeChiron Corporation
InventorsVenkatakrishna Shyamala, Patricia Tekamp Olson
Life of this patent
Estimating the term…
Abstract
A new endothelin B receptor has been identified, and the amino acid and nucleotide sequence of the receptor are provided. The nucleotide sequence is useful to construct expression cassettes and vectors to produce host cells which are capable of expressing the receptor, its mutants, fragments, or fusions. Such polypeptides are useful for identifying new endothelin agonists and antagonists.
Claims2
A method of screening for a test candidate that binds an endothelin B.sub.1 (ETB.sub.1) receptor polypeptide and modulates signal transduction activity comprising:
- (a) providing a host cell transformed with a DNA encoding endothelin B.sub.1, receptor (ETB.sub.1) polypeptide having SEQ ID NO:1;
- (b) exposing said cell to said test candidate;
- and
- (c) measuring endothelin B.sub.1 receptor signal transduction activity.
A method of screening for a test candidate that binds an endothelin B.sub.1 (ETB.sub.1) receptor polypeptide and modulates signal transduction activity comprising:
- (a) providing a host cell transformed with a DNA encoding endothelin B, receptor (ETB.sub.1) polypeptide having SEQ ID NO:1;
- (b) exposing said cell to said test candidate;
- (c) lysing said cell;
- and
- (d) measuring endothelin B.sub.1 receptor signal transduction activity.
Dependencies are inferred from the claim text.